In addition to these cardiac-specific biomarkers, C-reactive protein (CRP) and lipoprotein-associated phospholipase A2 (Lp-PLA2) have emerged as significant markers in the broader context of cardiovascular diseases. Here, CRP is linked to cardiovascular disorder.